Page last updated: 2024-09-05

lapatinib and vadimezan

lapatinib has been researched along with vadimezan in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010) (vadimezan)
1,9193051,44227216101

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)vadimezan (IC50)
Stimulator of interferon genes proteinMus musculus (house mouse)1.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ye, G; Zhang, C; Zhang, J1

Other Studies

1 other study(ies) available for lapatinib and vadimezan

ArticleYear
Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
    Aging, 2021, 08-30, Volume: 13, Issue:16

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Head and Neck Neoplasms; Humans; Interferons; Lapatinib; Male; Membrane Proteins; Mice, Inbred BALB C; Nucleotides, Cyclic; Pyridines; Receptor, ErbB-2; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor Receptor-2; Xanthones; Xenograft Model Antitumor Assays

2021